Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk
| dc.contributor.author | Ma, Yunsheng | |
| dc.contributor.author | Culver, Annie L. | |
| dc.contributor.author | Rossouw, Jacques E. | |
| dc.contributor.author | Olendzki, Barbara C. | |
| dc.contributor.author | Merriam, Philip A. | |
| dc.contributor.author | Lian, Bill | |
| dc.contributor.author | Ockene, Ira S. | |
| dc.date | 2022-08-11T08:10:21.000 | |
| dc.date.accessioned | 2022-08-23T17:05:21Z | |
| dc.date.available | 2022-08-23T17:05:21Z | |
| dc.date.issued | 2013-02-01 | |
| dc.date.submitted | 2013-01-18 | |
| dc.identifier.citation | Ther Adv Cardiovasc Dis. 2013 Feb;7(1):41-4. doi: 10.1177/1753944712468499. <a href="http://dx.doi.org/10.1177/1753944712468499" target="_blank">Link to article on publisher's site</a> | |
| dc.identifier.issn | 1753-9447 (Linking) | |
| dc.identifier.doi | 10.1177/1753944712468499 | |
| dc.identifier.pmid | 23238515 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/44839 | |
| dc.description.abstract | Purpose of review: The purpose of this review was to examine statin therapy and the risk for diabetes among adult women using a selective review. Recent findings: The literature contains reports of new-onset diabetes associated with statin use. While many studies do not report sex-specific results, there is evidence indicating the risk to benefit ratio may vary by gender. However, the absolute effects are not clear because women have historically been under-represented in clinical trials. Summary: A review of the literature indicates that the cardiovascular benefits of statins appear to outweigh the risk for statin-related diabetes. However, the effect may depend upon baseline diabetes risk, dose, and statin potency. Rigorous, long-term studies focused on the risks and benefits of statins in women are unavailable to sort for gender-specific differences. Until this changes, individualized attention to risk assessment, and strong prevention with lifestyle changes must prevail. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23238515&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1177/1753944712468499 | |
| dc.subject | Diabetes Mellitus, Type 2 | |
| dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
| dc.subject | Cardiovascular Diseases | |
| dc.subject | Community Health and Preventive Medicine | |
| dc.subject | Digestive System Diseases | |
| dc.subject | Endocrine System Diseases | |
| dc.subject | Preventive Medicine | |
| dc.subject | Women's Health | |
| dc.title | Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Therapeutic advances in cardiovascular disease | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/prevbeh_pp/261 | |
| dc.identifier.contextkey | 3588915 | |
| html.description.abstract | <p>Purpose of review: The purpose of this review was to examine statin therapy and the risk for diabetes among adult women using a selective review.</p> <p>Recent findings: The literature contains reports of new-onset diabetes associated with statin use. While many studies do not report sex-specific results, there is evidence indicating the risk to benefit ratio may vary by gender. However, the absolute effects are not clear because women have historically been under-represented in clinical trials.</p> <p>Summary: A review of the literature indicates that the cardiovascular benefits of statins appear to outweigh the risk for statin-related diabetes. However, the effect may depend upon baseline diabetes risk, dose, and statin potency. Rigorous, long-term studies focused on the risks and benefits of statins in women are unavailable to sort for gender-specific differences. Until this changes, individualized attention to risk assessment, and strong prevention with lifestyle changes must prevail.</p> | |
| dc.identifier.submissionpath | prevbeh_pp/261 | |
| dc.contributor.department | Department of Medicine, Division of Cardiovascular Medicine | |
| dc.contributor.department | Department of Medicine, Division of General Medicine | |
| dc.contributor.department | Department of Medicine, Division of Preventive and Behavioral Medicine |